Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent A Smith

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Studies in Health Technology and Informatics|February 1, 2022
Free MEDLINE Access WorldwideKent A Smith
Journal of the Medical Library Association : JMLA|April 2, 2008
Laws, leaders, and legends of the modern National Library of MedicineKent A Smith
Information Services & Use|June 20, 2022
Free MEDLINE access worldwideKent A Smith
Journal of the Medical Library Association : JMLA|October 10, 2012
Martin M. Cummings, AHIP, FMLA, 1920–2011Cheryl R Dee, Kent A Smith
Current Protocols in Immunology|April 25, 2008
Measurement of human and murine stem cell factor (c-kit ligand)Kent A Smith, Krisztina M Zsebo
Expert Review of Vaccines|October 9, 2013
Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventionsAdrian Bot, Francesco Marincola, Kent A Smith
DNA and Cell Biology|July 3, 2004
Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathologyAdrian Bot, Kent A Smith, Matthias von Herrath
Journal of Translational Medicine|December 15, 2010
Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunityAdrian Bot, Zhiyong Qiu, Raymond Wong, et al.
Journal of Virology|June 7, 2002
Targeting and hematopoietic suppression of human CD34+ cells by measles virusMarianne Manchester, Kent A Smith, Danelle S Eto, et al.
European Journal of Immunology|May 24, 2005
Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administrationBarbara R von Beust, Pål Johansen, Kent A Smith, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Studies in Health Technology and Informatics|February 1, 2022
Free MEDLINE Access WorldwideKent A Smith
Journal of the Medical Library Association : JMLA|April 2, 2008
Laws, leaders, and legends of the modern National Library of MedicineKent A Smith
Information Services & Use|June 20, 2022
Free MEDLINE access worldwideKent A Smith
Journal of the Medical Library Association : JMLA|October 10, 2012
Martin M. Cummings, AHIP, FMLA, 1920–2011Cheryl R Dee, Kent A Smith
Current Protocols in Immunology|April 25, 2008
Measurement of human and murine stem cell factor (c-kit ligand)Kent A Smith, Krisztina M Zsebo
Expert Review of Vaccines|October 9, 2013
Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventionsAdrian Bot, Francesco Marincola, Kent A Smith
DNA and Cell Biology|July 3, 2004
Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathologyAdrian Bot, Kent A Smith, Matthias von Herrath
Journal of Translational Medicine|December 15, 2010
Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunityAdrian Bot, Zhiyong Qiu, Raymond Wong, et al.
Journal of Virology|June 7, 2002
Targeting and hematopoietic suppression of human CD34+ cells by measles virusMarianne Manchester, Kent A Smith, Danelle S Eto, et al.
European Journal of Immunology|May 24, 2005
Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administrationBarbara R von Beust, Pål Johansen, Kent A Smith, et al.
Pageof 2